The Cancer Genome Atlas and the results from the analyses of clinical tumor samples demonstrated that the expression of PD-L2 is sometimes more highly correlated with antitumor immune responses than PD-L1 in case of renal cell cancer and lung squamous cell cancer13. Here, PDCD1LG2 is linked to cancer.